Michelle S Bradbury

This inventor holds 22 USPTO granted patents and 13 published patent applications, plus 4 CIPO patents and 10 EPO patents, primarily in Nanoparticle Therapeutics. Top assignees: Cornell University, Memorial Sloan Kettering Cancer Center, Sloan-Kettering Institute for Cancer Research. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michelle S Bradbury. Retrieved from https://idiyas.com/inventor/michelle-s-bradbury

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 13)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 6)

EPO Patents = 10 (Patent Applications = 19)

Average Co-Inventor Count = 5.2

ph-index = 7

Forward Citations = 104(Granted Patents)

Company Filing History:

Memorial Sloan Kettering Cancer Center

patents

6 out of 519

Sloan-Kettering Institute for Cancer Research

patents

4. 2 out of 2

Quest Medical Imaging B.v

patents

5. 2 out of 898

University of Missouri

patents

6. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2017-2026

Loading Chart...

Areas of Expertise:

Nanoparticle Therapeutics

Cancer Radiogenomics

Photodynamic Therapy

Fluorescent Imaging

Augmented Reality

Silica-Based Nanoparticles

Ultrasmall Nanoparticles

Cyclic Peptides

Immunoconjugates

Real-Time Imaging

Drug Conjugates

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12558438 - Imaging systems and methods for particle-driven, knowledge-based, and predictive cancer radiogenomics (2026-02-24),

2. 12268742 - Nanotherapeutic systems and methods using particle-driven photodynamic therapy (PDT) (2025-04-08),

3. 12161734 - Multimodal silica-based nanoparticles (2024-12-10),

4. 12082907 - Systems, methods, and apparatus for multichannel imaging of fluorescent sources in real-time (2024-09-10),

5. 11931425 - Methods of treatment using ultrasmall nanoparticles to induce cell death of nutrient-deprived cancer cells via ferroptosis (2024-03-19),

6. 11666411 - Systems for augmented reality surgical and clinical visualization (2023-06-06),

7. 11660354 - Inhibitor-functionalized ultrasmall nanoparticles and methods thereof (2023-05-30),

8. 11559591 - Ultrasmall nanoparticles labeled with Zirconium-89 and methods thereof (2023-01-24),

9. 11419955 - Multimodal silica-based nanoparticles (2022-08-23),

10. 11246946 - Methods of treatment using ultrasmall nanoparticles to induce cell death of nutrient-deprived cancer cells via ferroptosis (2022-02-15),

11. 10986997 - Systems, methods, and apparatus for multichannel imaging of fluorescent sources in real time (2021-04-27),

12. 10940216 - Cyclic peptides with enhanced nerve-binding selectively, nanoparticles bound with said cyclic peptides, and use of same for real-time in vivo nerve tissue imaging (2021-03-09),

13. 10736972 - Methods of treatment using ultrasmall nanoparticles to induce cell death of nutrient-deprived cancer cells via ferroptosis (2020-08-11),

14. 10548998 - Multimodal silica-based nanoparticles (2020-02-04),

15. 10548997 - Fluorescent silica-based nanoparticles (2020-02-04),

Title: The Innovative Journey of Michelle S Bradbury

Introduction: Michelle S Bradbury is a pioneering inventor based in New York, NY, known for her groundbreaking contributions to the field of technology and healthcare.

Latest Patents: Michelle S Bradbury holds several patents in the areas of medical devices, nanotechnology, and biotechnology, showcasing her versatility and ingenuity in creating solutions for complex challenges.

Career Highlights: With a career spanning over two decades, Michelle S Bradbury has worked tirelessly to develop cutting-edge technologies that have revolutionized the industry. Her commitment to innovation and excellence has earned her recognition as a leading figure in the field.

Collaborations: Throughout her career, Michelle S Bradbury has collaborated with top research institutions, universities, and companies to bring her inventions to life. Her ability to work across disciplines and forge meaningful partnerships has been instrumental in her success.

Conclusion: Michelle S Bradbury's passion for innovation, coupled with her dedication to improving lives through technology, continues to inspire the next generation of inventors. Her impact on the industry is profound, and her legacy will undoubtedly endure for years to come.

Profile summary based on public USPTO records.